MiNK Therapeutics (INKT) Misses Q2 EPS by 106c
Tweet
Share
E-mailGet Alerts INKT Hot Sheet
Join SI Premium – FREE
MiNK Therapeutics (NASDAQ: INKT) reported Q2 EPS of ($1.06).
For earnings history and earnings-related data on MiNK Therapeutics (INKT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Kepler Cheuvreux Upgrades Maire Tecnimont (MT:IM) to Buy
- Morgan Stanley Resumes Lakefront Biotherapeutics (LKFT) at Equalweight
- Trinity Capital posts $709M in new commitments for Q2 2026
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
